Interaction of Sr-doped hydroxy apatite nanocrystals with osteoclast and osteoblast-like cells

Journal of Biomedical Materials Research - Part A

Volumn 89, Issue 3, 2009, Pages 594-600

  Capuccini, C ^a   Torricelli, P ^b   Boanini, E ^a   Gazzano, M ^c   Giardino, R ^b   Bigi, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c CNR   (Italy)

Author keywords

Hydroxyapatite; Osteoblast; Osteoclast; Strontium

Indexed keywords

BONE CELLS; COLLAGEN TYPE I; DIFFERENTIATION PARAMETERS; DOPED SAMPLE; HYDROXYAPATITE NANOCRYSTALS; INHIBITORY EFFECT; IONIC RADIUS; MG63 CELLS; OSTEOBLAST-LIKE CELLS; OSTEOCALCIN; OSTEOCLAST; OSTEOCLAST PROLIFERATION; STRUCTURAL ORDERS; UNIT CELL PARAMETERS;

APATITE; ATOMS; CALCIUM; HYDROXYAPATITE; NANOCRYSTALS; OSTEOBLASTS; PHOSPHATE MINERALS;

STRONTIUM;

ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN TYPE 1; HYDROXYAPATITE; NANOCRYSTAL; OSTEOCALCIN; STRONTIUM;

ARTICLE; BONE CELL; CELL ACTIVITY; CELL INTERACTION; CELL PROLIFERATION; CELL STRUCTURE; CHEMICAL REACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOCLAST;

CELL DIFFERENTIATION; CELL PROLIFERATION; DURAPATITE; HUMANS; NANOPARTICLES; OSTEOBLASTS; OSTEOCLASTS; STRONTIUM; X-RAY DIFFRACTION;

EID: 66249149044     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31975     Document Type: Article

References (37)

1. Elliott JC. Structure and Chemistry of the Apatites and Other Calcium Orthophosphates. Amsterdam: Elsevier; 1994.
2. Blake GM, Zivanovic MA, McEwan AJ, Ackery DM. Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate. Eur ] Nucl Med 1986;12:447-154.
3. Marie PJ, Ammann P, Boivin G, Rey C. Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int 2001;69:121-129.
4. Marie PJ. Strontium ranelate: A novel mode of action optimizing bone formation and resorption. Osteoporos Int 2005;16:S7-S10.
5. Ammann P. Strontium ranelate: A novel mode of action leading to renewed bone quality. Osteoporos Int 2005;I6:S11-S15.
6. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ. The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 1996;18:517-523.
7. Chang W, Tu C, Chen T, Komuwes L, Oda Y, Pratt S, Miller S, Shoback D. Expression and signal transduction of calcium- sensing receptors in cartilage and bone. Endocrinology 1999;140:5883-5893.
8. Ammann P, Shen V, Robin B, Mauras Y, Bonjour JP, Rizzoli R. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. J Bone Miner Res 2004;19:2012-2020.
9. Grynpas MD, Hamilton E, Cheung R, Tsouderos Y, Deloffre P, Hott M, Marie PJ. Strontium increases vertebral bone volume in rats at a low dose that does not induce detectable mineralization defect. Bone 1996;18:253-259.
10. Marie PJ, Hott M, Modrowski D, DePollak C, Guillemain J, Deloffre P, Tsouderos Y. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 1993;8:607-615.
11. Marie PJ. Strontium ranelate: New insights into its dual mode of action. Bone 2007;40:S5-S8.
12. Leroux L, Lacout JL. Preparation of calcium strontium hydroxyapatites by a new route involving calcium phosphate cements. J Mater Res 2001;16:171-178.
13. Landi E, Tampieri A, Celotti G, Sprio S, Sandri M, Logroscino G. Sr-substituted hydroxyapatites for osteoporotic bone replacement. Acta Biomater 2007;3:961-969.
14. Panzavolta S, Torricelli P, Sturba L, Bracci B, Giardino R, Bigi A. Setting properties and in vitro bioactivity of strontium enriched gelatin-calcium phosphate bone cements. J Biomed Mater Res A 2008;84:965-972.
15. Xue W, Moore JL, Hosick HL, Bose S, Bandyopadhyay A, Lu WW, Cheung KMC, Luk KDK. Osteoprecursor cell response to strontium-containing hydroxyapatite ceramics. J Biomed Mater Res A 2006;79:804-814.
16. Jegou Saint-Jean S, Camirè CL, Nevsten P, Hansen S, Ginebra MP. Study of the reactivity and in vitro bioactivity of Sr-sub- stituted α-TCP cements. J Mater Sci Mater Med 2005;16:993- 1001.
17. Suchanek W, Yoshimura M. Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants. J Mater Res 1998;13:94-117.
18. Jha LJ, Best SM, Knowles JC, Rehman I, Santos JD, Bonfield W. Preparation and characterization of fluoride-substituted apatites. J Mater Sci Mater Med 1997;8:185-191.
19. Pezzatini S, Solito R, Morbidelli L, Lamponi S, Boanini E, Bigi A, Ziche M. The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions. J Biomed Mater Res A 2006;76:656-663.
20. Tadic D, Beckmann F, Schwarz K, Epple M. A novel method to produce hydroxyapatite objects with interconnecting porosity that avoids sintering. Biomaterials 2004;25:3335-3340.
21. Zhu K, Yanagisawa K, Shimanouchi R, Onda A, Kajiyoshi K. Preferential occupancy of metal ions in the hydroxyapatite solid solutions synthesized by hydrothermal method. J Eur Ceram Soc 2006;26:509-513.
22. Bigi A, Boanini E, Capuccini C, Gazzano M. Strontium-substituted hydroxyapatite nanocrystals. Inorg Chim Acta 2007;360: 1009-1016.
23. Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A. Nanocomposites of hydroxyapatite with aspartic acid and glutamic acid and their interaction with osteoblast-like cells. Biomaterials 2006;27:4428-433.
24. Bruckner S. Profile analysis of X-ray diffraction data from powder polymer samples. Chim Ind 1988;70:48-53.
25. Klug HP, Alexander LE. X-ray diffraction procedures for pol- ycrystalline and amorphous materials. New York: Wiley- Interscience; 1974.
26. Brunauer S, Emmett PH, Teller EJ. Adsorption of gases in multimolecular layers. J Am Chem Soc 1938;60:309-319.
27. Susa M, Luong-Nguyen N-H, Cappellen D, Zamurovic N, Gamse R. Human primary osteoclasts: In vitro generation and applications as pharmacological and clinical assay. J Transl Med 2004;2:6.
28. Husheem M, Nyman IK, Vaaraniemi J, Vaananen HK, Hentu- nen TA. Characterization of circulating human osteoclast progenitors: Development of in vitro resorption assay. Calcif Tissue Int 2005;76:222-230.
29. Greiner S, Kadow-Romacker A, Wildemann B, Schwabe P, Sehmidmaier G. Bisphosphonates incorporated in a poly(D,L- lactide) implant coating inhibit osteoclast like cells in vitro. J Biomed Mater Res A 2007;83:1184-1191.
30. Aubin JE, Liu F, Malaval L, Gupta AK. Osteoblast and chon- droblast differentiation. Bone 1995;17:77S-83S.
31. Franceschi RT, Iyer BS. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 1992;7:235-246.
32. Mayr-Wohlfahrt U, Fiedler J, Gunther KP, Puhl W, Kessler S. Proliferation and differentiation rates of a human osteoblast- like cell line (SaOS-2) in contact with different bone substitute materials. J Biomed Mater Res 2001;57:132-139.
33. Canalis E, Hott M, Deloffre P, Tsouderos Y, Marie PJ. The divalent strontium salt SI2911 enhances bone cell replication and bone formation in vitro. Bone 1996;18:517-523.
34. Verberckmoes SC, De Broe ME, D'Haese PC. Dose-dependent effects of strontium on osteoblast function and mineralization. Kidney Int 2003;64:534-543.
35. Qiu K, Zhao XJ, Wan CX, Zhao CS, Chen YW. Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffolds. Biomaterials 2006;27:1277- 1286.
36. Baron R, Tsouderos Y. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol 2002;450:11-17.
37. Takahashi N, Sasaki T, Tsouderos Y, Suda T. S 12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res 2003;18:1082-1087.